Approved Study Database

Ref. No. Scientific Title Principal investigator
2017.124 A Randomized Controlled Trial Comparing Prefrontal and Lateral Temporal Anodal Transcranial Direct Current Stimulation (tDCS) plus Working Memory Training in Chinese Older Adults with Mild Neurocognitive Disorder due to Alzheimer's Disease Prof. LAM Linda Chiu Wa
2017.125 Assessment of the effect of ageing on anal sphincter distensibility in Hong Kong using EndoFLIP Dr. FUTABA Kaori
二葉香織
2017.126 Evaluation of Service for Student Mental Health Support Scheme Prof. LAI Kelly Yee Ching
黎以菁
2017.127 Prospective randomized trial comparing Endoscopic Sleeve Gastroplasty versus conventional Laparoscopic Sleeve Gastrectomy in Patients with Morbid Obesity: From Physical and Functional Outcomes to Changes in Hormonal profiles Prof. NG Enders Kwok Wai
吳國偉
2017.128 Deciphering the properties of cell-free DNA in systemic lupus erythematosus with genomewide sequencing Prof. JIANG Peiyong
江培勇
2017.129 Prodromal markers of α-synucleinopathy neurodegeneration in the first-degree relatives of patients with psychiatric disorders comorbid with REM sleep behavior disorder Prof. WING Yun Kwok
榮潤國
2017.130 Genome-wide CRISPR screen for host factors associated with norovirus infections in stem cell-derived human intestinal enteroid model Dr. CHAN Martin Chi Wai
陳子蔚
2017.131 Asparaginase activity and inhibitor in Chinese patients Prof. LI Chi Kong
李志光教授
2017.132 Comparisons between two exercise programs in pre-frail and frail Chinese elderly: a randomized controlled trial Dr. YU Ruby H.Y.
余浩欣
2017.133 Adenomyosis in infertility patients and those with recurrent implantation failure Dr. CHUNG Jacqueline Pui Wah
2017.134 Role of senescence marker p16INK4a measured in peripheral blood T-lymphocytes in predicting cognitive decline in older diabetic outpatients Dr. KWOK Timothy
郭志銳
2017.135 Clinical classification of osteogenesis imperfecta and genotype-phenotype correlation in local Chinese patients Dr. CHONG Shuk Ching
莊淑貞醫生
2017.136 Changes in Semantic Processing across the Adult Lifespan: A Cross-sectional Electrophysiological Investigation Dr. WONG Adrian
黃沛霖
2017.137 Investigating antibiotic resistance of Helicobacter pylori and its genomic landscape Dr. WONG Sunny Hei
黃曦
2017.138 An investigation into the maternal blood transcriptome before the onset of preterm labor: toward an early detection of preterm birth Prof. CHIM Stephen Siu Chung
詹兆冲
2017.139 A randomized controlled trial to evaluate the effectiveness of an ehealth antenatal exercise intervention in improving lumbopelvic pain in Hong Kong Chinese pregnant women Mrs. AU YEUNG Elce
歐陽凱詩
2017.140 The pathophysiology of olfactory dysfunction as a late toxicity following primary treatment of nasopharyngeal carcinoma Dr. CHAN Jason
2017.141 Novel TIR device for fast in vivo terahertz imaging Prof. MacPHERSON Emma
N/A
2017.142 Modulation of cognition and brain activity in children by music training Prof. CHEUNG Mei Chun
張美珍
2017.143 Association between oral microbiome, HPV and human epigenetic events in head and neck squamous cell carcinoma Prof. CHEN Zigui
2017.144 The first Hong Kong study to explore prevalence and risk factors for the emergence of antibiotic resistant Mycoplasma genitalium (MG) among sexually transmitted infection (STI) female patients Dr. CHUNG Pui Hong
2017.145 RAC1 Genomic Alterations Drive Head and Neck Cancer Progression Dr. LUI Vivian Wai Yan
呂偉欣
2017.146 Circulating microRNAs as biomarkers for predicting the early development, repair and progression of bone erosions in early rheumatoid arthritis using HR-pQCT Prof. TAM Lai Shan
譚麗珊
2017.147 Effect of Erythropoiesis-Stimulating Agent therapy in Patients Receiving Palliative Care of Chronic Kidney Disease Dr. CHOW Kai Ming
周啟明
2017.148 Towards WHO End TB Strategy - Decision tree analysis and Markov modelling for the impact of LTBI and TB screening in elderly in Hong Kong Dr. CHUNG Pui Hong
2017.149 Respiratory Syncytial Virus infection in paediatric patients in Hong Kong: disease and economic burden Prof. NELSON Edmund Anthony
倪以信
2017.150 Inclusion and use of vaccines in Hong Kong's mixed Public-Private funding model of health care Prof. NELSON Edmund Anthony
倪以信
2017.151 Registry of oculoplastic and adnexal disorders (ROAD) Dr. CHONG Kelvin Kam Lung
莊金隆
2017.152 Whole Genome Sequencing-based characterization of Carbapenem-resistant Enterobacteriaceae in Hong Kong Prof. IP Margaret
2017.153 Adjuvant Transarterial Chemoembolisation After Curative Hepatectomy For Hepatocellular Carcinoma: A Randomized Controlled Trial Dr. CHONG Charing Ching Ning
莊清寧
2017.154 The impact of personality disorder on outcome of depression: a systematic review and meta-analysis Miss WONG Ching Yi
黃清怡
2017.155 Using neuroimage and computational modeling to customize high-definition transcranial direct current stimulation protocols for facilitating hand function recovery after stroke Prof. TONG Kai Yu
湯啟宇
2017.157 The role and clinical impact of SQLE in promoting non-alcoholic fatty liver disease through inducing intracellular cholesterol ester accumulation Prof. YU Jun
于君
2017.159 Creating a Novel Topical Agent of Herbal Origin for Atopic Dermatitis through Evidence-Based Research Procedures Prof. HON Ellis Kam Lun
韓錦倫
2017.160 Elucidating the molecular mechanisms of a novel tumor suppressor gamma-glutamyltransferase 7 in inhibiting gastric cancer Dr. LIANG Jessie Qiaoyi
梁巧儀
2017.161 Functional importance and clinical application of the novel fusion gene DDX5-POLG2 in gastric cancer Dr. LIANG Jessie Qiaoyi
梁巧儀
2017.162 A retrospective study on the use of capecitabine and irinotecan combination therapy (XELIRI) in patients with metastatic colorectal cancer. Dr. WONG Kwan Hung
黃鈞雄
2017.163 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis Prof. WONG Vincent Wai Sun
黃煒燊
2017.164 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis Dr. HUI Aric Josun
許祖紳
2017.165 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) Dr. HUI Aric Josun
許祖紳
2017.166 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) Prof. WONG Vincent Wai Sun
黃煒燊
2017.167 Single-center, randomized, double-blind, placebo-controlled, single-dose and multiple-dose, parallel-group study to investigate pharmacokinetics, pharmacodynamics, safety and tolerability of vericiguat in Chinese healthy male subjects under fed condition Dr. LUK Andrea On Yan
陸安欣
2017.168 Development of non-invasive prenatal screening test for multiple gestation pregnancies using cell-free DNA Dr. CHOY Kwong Wai
蔡光偉
2017.169 Open label single arm study for NEPA [oral fixed-dose combination of 300 mg netupitant and 0.50 mg palonosetron] in Hong Kong oncology patients receiving (neo)-adjuvant chemotherapy treatment consists of adriamycin and cyclophosphamide for breast cancer. Prof. YEO Winnie
2017.170 Impact of Metabolic syndrome and Body Composition on Bone Mineral Density in HIV-infected individuals in Hong Kong Dr. LUI Grace Chung Yan
雷頌恩
2017.171 Longitudinal study of young adults with aggressive lymphomas for bone density changes after chemotherapy and its correlation with cytokine profile Dr. RAGHUPATHY Radha
2017.172 DETECTION AND QUANTIFICATION OF T790M and C797S MUTATIONS VIA DIGITAL DROPLET POLYERMASE CHAIN REACTION (ddPCR) IN LUNG CANCER PATIENTS ON OSIMERTINIB TREATMENT Dr. LOONG Herbert Ho Fung
龍浩鋒醫生
2017.173 Gestational normal values of Sylvian angle at 14-36 weeks’ gestation Prof. POON Liona Chiu Yee
潘昭頤
2017.176 Function of docking protein-1 in immunotherapy of gastric cancer Prof. YU Jun
于君
2017.177 A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Switching from Tenofovir Disoproxil Fumarate (TDF) 300 mg QD to Tenofovir Alafenamide (TAF) 25mg QD in Subjects with Chronic Hepatitis B who are Virologically Suppressed Dr. CHAN Lik Yuen
陳力元

Page 156 of 254.